Tag Archives: GILD

Atara Biotherapeutics: What Q1 2018 Earnings Foretell?

The big money is not in the buying and selling. But in the waiting. – Charlie Munger

Atara Biotherapeutics (NASDAQ:ATRA) is one of the most promising growers that weve encountered thus far. As follows, the company is hitting its growth inflection with a key late-stage T-cell immunotherapeutic (tab-cel, formerly known as ATA-129). In anticipating the strong data reporting, the....More>>>

Sangamo Therapeutics Stock History

If you’ve been following the news lately, you might have heard about gene editing, a process that involves rewriting a person’s DNA to correct genetic disorders, and you’re wondering what all the buzz is about.

While gene editing is getting a lot of attention recently, it’s far from a new idea. Sangamo Therapeutics (NASDAQ:SGMO) has been working on gene-editing research....More>>>

Sangamo Therapeutics Stock History

If you’ve been following the news lately, you might have heard about gene editing, a process that involves rewriting a person’s DNA to correct genetic disorders, and you’re wondering what all the buzz is about.

While gene editing is getting a lot of attention recently, it’s far from a new idea. Sangamo Therapeutics (NASDAQ:SGMO) has been working on gene-editing research....More>>>

Your Daily Pharma Scoop: Biohaven Updates, MEIP Offering, Kite European Expansions

Analysis focus: BHVN

Biohaven Pharmaceuticals (NYSE:BHVN) is a CNS-focused company with a strong pipeline with multiple drug candidates in late stage trials. The company recently announced a number of updates for its pipeline. For its lead candidate, rimegepant from the CGRP receptor antagonist platform, the company will report initial results from a long-term safety study in Q4 2018. In....More>>>

Top 5 Low Price Stocks To Buy For 2018

For years, Toys “R” Us was an American success story.

Now the discount toy retailer is in its final chapter. The company filed for bankruptcy in September. On Wednesday, Toys “R” Us told employees that it would close or sell all its stores in the United States.

It’s an ignominious end for the company that was once the toy industry’s powerhouse.....More>>>